한글목차

세계의 관절통 주사 시장 규모는 2024년에 46억 6,000만 달러로 평가되었고, 2030년에는 CAGR 7.02%로 강력한 성장이 전망됩니다.

이 시장 부문은 골관절염 및 류마티스 관절염과 같은 관절 관련 질환의 전 세계적인 발병률 증가에 부응합니다. 관절 통증 주사는 만성 관절 통증과 염증을 관리하기 위해 수술에 대한 최소 침습적이고 효과적인 대안을 제공합니다. 이러한 치료에는 코르티코스테로이드, 히알루론산, 다혈소판 혈장(PRP) 주사, 태반 조직 매트릭스 주사가 포함되며, 모두 통증을 줄이고 이동성을 개선하며 전반적인 관절 기능을 향상시키기 위해 고안되었습니다. 전 세계 인구의 고령화와 비수술적 치료 옵션에 대한 수요 증가로 시장 확대가 가속화되고 있습니다.

시장 성장 촉진요인

비만률 상승

주요 시장 과제

환급 문제

주요 시장 동향

생물학적 제제 및 재생 치료의 발전

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 목소리

제5장 세계의 관절통 주사 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율 및 예측
  • 주사 유형별(스테로이드 관절 주사, 히알루론산 주사, 다혈소판 혈장(PRP) 주사, 태반 조직 매트릭스(PTM) 주사, 기타)
  • 용도별(어깨 및 팔꿈치, 무릎 및 발목, 척추 관절, 고관절, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵
  • 주사 유형별
  • 용도별
  • 지역별

제6장 북미의 관절통 주사 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 관절통 주사 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 유럽 : 국가별 분석
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인

제8장 아시아태평양의 관절통 주사 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 일본
  • 인도
  • 호주
  • 한국

제9장 남미의 관절통 주사 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 관절통 주사 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근 동향
• 합병과 인수
• 제품 출시

제13장 Porter's Five Forces 분석

• 업계 내 경쟁
• 신규 진입의 가능성
• 공급자의 힘
• 고객의 힘
• 대체품의 위협

제14장 경쟁 구도

• Anika Therapeutics Inc
• Bioventus LLC
• Ferring Pharmaceuticals Inc
• Sanofi SA
• Pfizer Inc
• Eli Lilly & Co
• Flexion Therapeutics Inc
• Teva Pharmaceutical Industries Ltd
• Zimmer Biomet Holdings, Inc.

제15장 전략적 제안

제16장 기업 소개와 면책사항

영문목차

The Global Joint Pain Injections Market was valued at USD 4.66 billion in 2024 and is expected to witness robust growth, reaching significant market potential by 2030 with a CAGR of 7.02%. This market segment caters to the rising global incidence of joint-related disorders such as osteoarthritis and rheumatoid arthritis. Joint pain injections offer a minimally invasive and effective alternative to surgery for managing chronic joint pain and inflammation. These treatments include corticosteroids, hyaluronic acid, platelet-rich plasma (PRP), and placental tissue matrix injections, all designed to reduce pain, improve mobility, and enhance overall joint function. The aging global population and increasing demand for non-surgical treatment options are accelerating market expansion.

Key Market Drivers

Rising Obesity Rates

The growing prevalence of obesity is a key driver propelling the demand for joint pain injections worldwide. As obesity rates rise, so does the burden on weight-bearing joints, increasing the risk of joint disorders like osteoarthritis. According to the World Health Organization, the number of obese individuals has significantly increased over the past few decades, with over 650 million people classified as obese in 2016. Excess weight leads to greater stress on joints, resulting in chronic pain and inflammation that often necessitates medical intervention. Joint pain injections offer an effective solution for managing this discomfort and are increasingly sought after as part of long-term pain management strategies in obese populations.

Key Market Challenges

Reimbursement Issues

Reimbursement limitations pose a significant barrier to the widespread adoption of joint pain injections. In many healthcare systems, inadequate insurance coverage discourages patients from opting for injection-based therapies due to high out-of-pocket expenses. This is particularly true for newer or biologic-based treatments, which tend to be more expensive. As a result, despite clinical efficacy, limited reimbursement frameworks can hinder market growth by restricting patient access to advanced treatment options.

Key Market Trends

Advancements in Biologics and Regenerative Therapies

Technological progress in biologics and regenerative medicine is shaping a major trend in the joint pain injections market. Treatments such as platelet-rich plasma (PRP) and placental tissue matrix (PTM) injections are gaining attention for their ability to promote tissue repair and deliver extended relief from joint pain. These therapies utilize the patient's own biological components or donor-derived materials to regenerate damaged tissues, offering an innovative approach to joint restoration. Continued R&D in this area is expected to yield next-generation injectable solutions that offer superior outcomes and durability, further enhancing patient appeal and clinical adoption.

Key Market Players

• Anika Therapeutics Inc
• Bioventus LLC
• Ferring Pharmaceuticals Inc
• Sanofi SA
• Pfizer Inc
• Eli Lilly & Co
• Flexion Therapeutics Inc
• Teva Pharmaceutical Industries Ltd
• Zimmer Biomet Holdings, Inc.

Report Scope:

In this report, the Global Joint Pain Injections Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Joint Pain Injections Market, By Type of Injection:

• Steroid Joint Injections
• Hyaluronic Acid Injections
• Platelet-rich Plasma (PRP) Injections
• Placental Tissue Matrix (PTM) Injections
• Others

Joint Pain Injections Market, By Application:

• Shoulder & Elbow
• Knee & Ankle
• Spinal Joints
• Hip Joint
• Others

Joint Pain Injections Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Joint Pain Injections Market.

Available Customizations:

Global Joint Pain Injections market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Joint Pain Injections Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
  • 5.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Type of Injection
  • 5.3.2. By Application
  • 5.3.3. By Region

6. North America Joint Pain Injections Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
  • 6.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Joint Pain Injections Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type of Injection
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Joint Pain Injections Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type of Injection
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Joint Pain Injections Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type of Injection
      • 6.3.3.2.2. By Application

7. Europe Joint Pain Injections Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
  • 7.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Joint Pain Injections Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type of Injection
      • 7.3.1.2.2. By Application
  • 7.3.2. United Kingdom Joint Pain Injections Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type of Injection
      • 7.3.2.2.2. By Application
  • 7.3.3. France Joint Pain Injections Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type of Injection
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Joint Pain Injections Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type of Injection
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Joint Pain Injections Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type of Injection
      • 7.3.5.2.2. By Application

8. Asia-Pacific Joint Pain Injections Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
  • 8.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Joint Pain Injections Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type of Injection
      • 8.3.1.2.2. By Application
  • 8.3.2. Japan Joint Pain Injections Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type of Injection
      • 8.3.2.2.2. By Application
  • 8.3.3. India Joint Pain Injections Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type of Injection
      • 8.3.3.2.2. By Application
  • 8.3.4. Australia Joint Pain Injections Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type of Injection
      • 8.3.4.2.2. By Application
  • 8.3.5. South Korea Joint Pain Injections Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type of Injection
      • 8.3.5.2.2. By Application

9. South America Joint Pain Injections Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
  • 9.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Joint Pain Injections Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type of Injection
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Joint Pain Injections Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type of Injection
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Joint Pain Injections Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type of Injection
      • 9.3.3.2.2. By Application

10. Middle East and Africa Joint Pain Injections Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
  • 10.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Joint Pain Injections Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type of Injection
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Joint Pain Injections Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type of Injection
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Joint Pain Injections Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type of Injection
      • 10.3.3.2.2. By Application
  • 10.3.4. Kuwait Joint Pain Injections Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Type of Injection
      • 10.3.4.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Anika Therapeutics Inc
• 14.2. Bioventus LLC
• 14.3. Ferring Pharmaceuticals Inc
• 14.4. Sanofi SA
• 14.5. Pfizer Inc
• 14.6. Eli Lilly & Co
• 14.7. Flexion Therapeutics Inc
• 14.8. Teva Pharmaceutical Industries Ltd
• 14.9. Zimmer Biomet Holdings, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer